News | September 11, 2013

Proton Therapy Center Opens in Prague

September 11, 2013 -- Cancer patients from all over the world now have a new opportunity to access proton therapy at the Proton Therapy Center Czech in Prague. It is only the fifth such center in Europe and currently the most well equipped centre in the world. The facility is attracting child and adult cancer patients from around the world seeking advanced cancer care with few treatment-related side effects.

With two of five treatment rooms running, the center is now treating head and neck tumours, lung cancer, melanoma of the eye and pancreatic cancer - indications that are difficult to treat by conventional radiotherapy. Besides that, the center offers a made to measure program for treatment of kids (anesthesia, special rooms and coloring books from Prof Proton series). The benefits for the patients are mainly lower damage of healthy tissue, less side effects and complications and better chances of cure. “The initial clinical experience has been very good and we have already treated different pediatric indications such as medulobllastoma, mediastinum or orbital tumor”, says Professor Manfred Herbst, the current health director of the center in Czech and former pioneer of proton therapy in Germany.

The Proton Therapy Center in Prague has a team of cancer specialists – including radiation oncologists, pediatric oncologists, nurses, research & quality controllers, radiation therapists, pediatric anesthesiologists, medical dosimetrists who specialize in treatment planning, physicists and other cancer professionals.

The Proton Therapy Center in Prague uses the world's most advanced cancer treatment technology. All treatment rooms are fitted with 'pencil-beam scanning' nozzles. Tumours are targeted with millimeter accuracy, sparing healthy tissues and controlling cancer more effectively than ever before. The treatment process itself is completely painless with minimal side-effects.

For more information, visit http://en.ptc.cz/

Related Content

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), explains the details of the proposed radiation oncology alternative payment model (APM), and issues ASTRO has raised with the model, at the 2019 ASTRO annual meeting in Chicago.

News | Radiation Oncology | September 18, 2019
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the...
Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...
Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...